跳至主要内容
临床试验/NCT06855862
NCT06855862已完成不适用

An Exploration of the Relationship Between Serum Cytokine Levels and the Clinical Efficacy of Vedolizumab

Second Affiliated Hospital of Wenzhou Medical University1 个研究点 分布在 1 个国家目标入组 105 人开始时间: 2020年11月5日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
105
试验地点
1
主要终点
The partial Mayo score was applied to evaluate the clinical activity UC patients

研究概览

简要总结

It is uncertain the relationship between serum cytokine levels and the clinical efficacy of vedolizumab in the treatment of ulcerative colitis. The effects of cytokines on the efficacy of vidrecizumab in Chinese UC patients were retrospectively analyzed. Methods: Patients with UC were recorded. These patients were detected the levels of cytokines.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •UC patients Treated with Vedolizumab

排除标准

  • •had cognitive/developmental disorders that affected their ability to complete the study procedures
  • •had medical illness or therapies potentially affecting bone, nutrition or growth status

结局指标

主要结局

The partial Mayo score was applied to evaluate the clinical activity UC patients

时间窗: 16 week and 34 week

次要结局

未报告次要终点

研究者

发起方
Second Affiliated Hospital of Wenzhou Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验